Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Albert Luderer; Leroy Hood; and More

Premium

BioNano Genomics said this week that it has elected Albert Luderer to its board of directors.

Luderer currently serves as CEO and director of Integrated Diagnostics. He was previously president and CEO of BioTrove, now part of Life Technologies. Previously, he served as CEO of Light Sciences and president and COO of BioMérieux.


The Personalized Medicine Coalition has awarded Leroy Hood its 2011 Leadership in Personalized Medicine Award for his "pioneering vision to transform medicine from reactive to predictive, preventive, personalized and participatory (P4 medicine)."

Hood is the president and co-founder of the Institute of Systems Biology, as well as a founder of more than a dozen biotechnology firms including Applied Biosystems, Amgen, and Integrated Diagnostics.


BG Medicine has signed a consulting agreement with Stéphane Bancel, who became chairman of its board of directors in July, that will pay him a fee of $150,000 per year and a consulting bonus up to $50,000 per year.

Bancel formerly was CEO of BioMérieux and an executive at Eli Lilly Laboratories.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.